COME HOME Treatment Pathways
Evidence Based, Physician Driven, Open Source
The COME HOME treatment pathways are developed and maintained by committees of community and academic oncologists. They are a freely available open source tool. New pathway committees meet twice monthly during pathway construction, and then quarterly to update the pathways and keep them current.
Click Cancer Type, then use additional navigation above footer or in left margin for Stage Specific Pathways. | ||
---|---|---|
Cancer Type | Stage | Updated |
Breast Cancer | DCIS Stage I-III Recurrent or Stage IV: ER or PR pos Recurrent or Stage IV ER/PR neg or endocrine refractory |
|
Colon Cancer | Stage II Stage III Stage IV PS 0-2 Stage IV PS 3-4 |
2017 . 07 . 28 |
Hodgkin Lymphoma | Stage IA or IIA Favorable Stage I-II Unfavorable Stage III-IV Refractory Disease |
|
Melanoma | Stage 0-IA Resectable Stage IB or II Unresectable Stage III-IV Good PS (0-2) Unresectable Stage III-IV Poor PS (3-4) |
|
Non-Small Cell Lung Cancer (NSCLC) | Stage IA Stage IB, IIA, IIB Stage IIIA Stage IIIB Metastatic Dis 1st line Rx Non-Squamous Metastatic Dis 1st line Rx Squamous Metastatic Dis 2nd line Rx |
2017 . 08 . 18 |
Pancreatic Cancer | Neoadjuvant Adjuvant Locally Advanced Metastatic or Recurrent |
2017 . 09 . 15 |
Thyroid Cancer | Metastatic Follicular, Hurthle Cell, Papillary Anaplastic Medullary |